Sevo Nutraceuticals, founded in June 2012, is a medical company dedicated to developing efficacious, science-backed nutraceuticals aimed at improving people's lives. The company's core mission is to enhance health and well-being through innovative, research-driven products. Their flagship product, PERCEPTIV®, launched in August 2012, is a patented formula designed to support cognitive health. This product is based on extensive research funded by UMASS Lowell, the Alzheimer's Association, the National Institute on Aging, and the National Science Foundation.
Notable affiliations include UMASS Lowell, which licensed the intellectual property for PERCEPTIV®. The company's achievements include securing patents and trademarks for their flagship product, which has garnered attention for its potential benefits in cognitive health. Sevo Nutraceuticals has made a significant impact by providing science-based solutions that address critical health concerns, thereby contributing to the broader field of nutraceuticals and cognitive wellness.
Quick Facts
How much disclosed funding has Sevo Nutraceuticals raised?
As of Jan 5, 2015, Sevo Nutraceuticals has disclosed funding of $300k (USD).